FDA Announces Submission of Information Collection for Sterility Requirements of Aqueous-Based Drug Products for Oral Inhalation

Summary

The Food and Drug Administration (FDA) is requesting public comment on the proposed collection of information related to the sterility requirements for aqueous-based drug products intended for oral inhalation, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.